Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review.
Ruiz-García A, Pallarés-Carratalá V, Serrano-Cumplido A, Escobar-Cervantes C, Barquilla-García A, Divisón-Garrote JA, Turégano-Yedro M, Prieto-Díaz MA, Cinza-Sanjurjo S, Alonso-Moreno FJ, Beato-Fernández P, García-Matarín L, Rey-Aldana D, Martín-Rioboó E, Moyá-Amengual A, Crespo-Sabarís R, Piera-Carbonell A, Romero-Vigara JC, Carrasco-Carrasco E, Velilla-Zancada S, Seoane-Vicente MC, Górriz-Teruel JL, Polo-García J, Barrios V; SEMERGEN Working Group on Hypertension, Cardiovascular Disease.
Ruiz-García A, et al. Among authors: moya amengual a.
Semergen. 2022 May-Jun;48(4):275-292. doi: 10.1016/j.semerg.2021.12.002. Epub 2022 Feb 15.
Semergen. 2022.
PMID: 35181226
Review.